These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9988537)
1. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537 [TBL] [Abstract][Full Text] [Related]
2. Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis. van Pelt JP; de Jong EM; de Bakker ES; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 1998; 11(2):70-9. PubMed ID: 9603657 [TBL] [Abstract][Full Text] [Related]
3. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid. Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669 [TBL] [Abstract][Full Text] [Related]
4. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800 [TBL] [Abstract][Full Text] [Related]
5. Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment. Gerritsen MJ; van Pelt JP; van de Kerkhof PC Acta Derm Venereol; 1996 Jan; 76(1):6-9. PubMed ID: 8721480 [TBL] [Abstract][Full Text] [Related]
6. Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis. Kuijpers AL; Schalkwijk J; Rulo HF; Peperkamp JJ; van de Kerkhof PC; de Jong EM Br J Dermatol; 1997 Jul; 137(1):123-9. PubMed ID: 9274639 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole. Dockx P; Decree J; Degreef H Br J Dermatol; 1995 Sep; 133(3):426-32. PubMed ID: 8546999 [TBL] [Abstract][Full Text] [Related]
8. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880 [TBL] [Abstract][Full Text] [Related]
9. Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. Alkemade HA; de Jongh GJ; Arnold WP; van de Kerkhof PC; Schalkwijk J J Invest Dermatol; 1995 Feb; 104(2):189-93. PubMed ID: 7829874 [TBL] [Abstract][Full Text] [Related]
11. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study. Bhushan M; Burden AD; McElhone K; James R; Vanhoutte FP; Griffiths CE Br J Dermatol; 2001 Oct; 145(4):546-53. PubMed ID: 11703279 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin. Werner B; Bresch M; Brenner FM; Lima HC J Cutan Pathol; 2008 Mar; 35(3):302-10. PubMed ID: 18251745 [TBL] [Abstract][Full Text] [Related]
13. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation? Kuijpers AL; Zeeuwen PL; de Jongh GJ; van de Kerkhof PC; Alkemade HA; Schalkwijk J Arch Dermatol Res; 1996 Oct; 288(11):641-7. PubMed ID: 8931865 [TBL] [Abstract][Full Text] [Related]
15. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. Alkemade JA; Molhuizen HO; Ponec M; Kempenaar JA; Zeeuwen PL; de Jongh GJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC; Schalkwijk J J Cell Sci; 1994 Aug; 107 ( Pt 8)():2335-42. PubMed ID: 7983189 [TBL] [Abstract][Full Text] [Related]
16. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris. Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study. Dogra S; Jain A; Kanwar AJ J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881 [TBL] [Abstract][Full Text] [Related]
18. Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse. Hsia E; Johnston MJ; Houlden RJ; Chern WH; Hofland HE J Invest Dermatol; 2008 Jan; 128(1):125-30. PubMed ID: 17637822 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901 [TBL] [Abstract][Full Text] [Related]
20. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. Kang S; Duell EA; Kim KJ; Voorhees JJ J Invest Dermatol; 1996 Aug; 107(2):183-7. PubMed ID: 8757760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]